Loading...
Critical appraisal of the use of regorafenib in the management of colorectal cancer
The lack of valid clinical management options for patients affected by metastatic colorectal cancer, which has progressed after all approved standard treatments, has lead to research into new active molecules. Regorafenib is an oral small-molecule multi kinase inhibitor, binding to several intracell...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3628528/ https://ncbi.nlm.nih.gov/pubmed/23610528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S34281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|